Collin J Van Ryn

20162019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

Neuroblastoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
3-Iodobenzylguanidine Medicine & Life Sciences
Vesicular Monoamine Transport Proteins Medicine & Life Sciences
Isotretinoin Medicine & Life Sciences
Neuropeptide Y Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group phase II study

Shusterman, S., Naranjo, A., van Ryn, C., Hank, J. A., Parisi, M. T., Shulkin, B. L., Servaes, S., London, W. B., Shimada, H., Gan, J., Gillies, S. D., Maris, J. M., Park, J. R. & Sondel, P. M., Oct 15 2019, In : Clinical Cancer Research. 25, 20, p. 6044-6051 8 p.

Research output: Contribution to journalArticle

Isotretinoin
Neuroblastoma
Granulocyte-Macrophage Colony-Stimulating Factor
Residual Neoplasm
Interleukin-2

Prevalence and clinical correlations of somatostatin receptor-2 (SSTR2) expression in neuroblastoma

Alexander, N., Marrano, P., Thorner, P., Naranjo, A., Van Ryn, C. J., Martinez, D., Batra, V., Zhang, L., Irwin, M. S. & Baruchel, S., Apr 1 2019, In : Journal of pediatric hematology/oncology. 41, 3, p. 222-227 6 p.

Research output: Contribution to journalArticle

Neuroblastoma
Norepinephrine Plasma Membrane Transport Proteins
somatostatin receptor 2
Somatostatin Receptors
Histology

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study

Braunstein, S. E., London, W. B., Kreissman, S. G., Villablanca, J. G., Davidoff, A. M., DeSantes, K., Castleberry, R. P., Murray, K., Diller, L., Matthay, K., Cohn, S. L., Shulkin, B., von Allmen, D., Parisi, M. T., Van Ryn, C. J., Park, J. R., La Quaglia, M. P. & Haas-Kogan, D. A., Jul 1 2019, In : Pediatric Blood and Cancer. 66, 7, e27736.

Research output: Contribution to journalArticle

Neuroblastoma
Disease-Free Survival
Radiotherapy
Lymph Nodes
Survival
7 Citations (Scopus)

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: A report from the children's oncology group

Niemas-Teshiba, R., Matsuno, R., Wang, L. L., Tang, X. X., Chiu, B., Zeki, J., Coburn, J., Ornell, K., Naranjo, A., Ryn, C. V., London, W. B., Hogarty, M. D., Gastier-Foster, J. M., Look, A. T., Park, J. R., Maris, J. M., Cohn, S. L., Seeger, R. C., Asgharzadeh, S., Ikegaki, N. & 1 others, Shimada, H., Jan 1 2018, In : Oncotarget. 9, 5, p. 6416-6432 17 p.

Research output: Contribution to journalArticle

Open Access
Neuroblastoma
Mitosis
Proteins
Survival
Neoplasms
22 Citations (Scopus)

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

Campbell, K., Gastier-Foster, J. M., Mann, M., Naranjo, A. H., Van Ryn, C., Bagatell, R., Matthay, K. K., London, W. B., Irwin, M. S., Shimada, H., Granger, M. M., Hogarty, M. D., Park, J. R. & DuBois, S. G., Nov 1 2017, In : Cancer. 123, 21, p. 4224-4235 12 p.

Research output: Contribution to journalArticle

Open Access
Neuroblastoma
Neoplasms
Disease-Free Survival
Survival
Proportional Hazards Models